S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Fund/RTW Investments/Q2 2021

RTW Investments

Periodo: Q2 2021 Β· Depositato: 2021-08-13
Vedi su SEC EDGAR β†—
AUM
$6.63B
Valore totale del portafoglio
Posizioni
113
Titoli dichiarati
Prima Posizione
RCKT
10.0% $663.9M
Var. Trimestrali
+8 / -8
nuovi Β· usciti
⚠️Informativa sui Depositi 13F

I dati AUM mostrati sono calcolati sommando il valore di mercato dichiarato di tutte le posizioni nei depositi SEC 13F-HR β€” non rappresentano il patrimonio effettivo gestito dal fondo.

  • Escluse liquiditΓ , obbligazioni, private equity, posizioni corte e azioni estere non soggette all'obbligo di dichiarazione.
  • Per le opzioni PUT e CALL, il Valore dichiarato Γ¨ il valore nozionale delle azioni sottostanti β€” non il premio pagato. CiΓ² sovrastima significativamente il capitale effettivamente a rischio.
  • Il patrimonio reale del fondo Γ¨ tipicamente superiore e include strategie, strumenti e posizioni che non compaiono mai in un 13F.
  • I depositi 13F riguardano i gestori istituzionali con β‰₯$100M in titoli 13F. Le posizioni riflettono le partecipazioni a fine trimestre, divulgate entro 45 giorni dalla fine del periodo.

Dati provenienti da SEC EDGAR. Questo tracker Γ¨ a scopo puramente informativo e non costituisce consulenza finanziaria.

Partecipazioni in Portafoglio

Prime 30 posizioni

⚠️ Performance % calcolata dalla data di deposito ( 2021-08-13) si riferisce al titolo sottostante β€” non al P&L del derivato.
TickerEmittenteNozionalePortafoglio %Al DepositoOra (Fine Giornata)Dal DepositoAllocazione
RCKTROCKET PHARMACEUTICALS INC$663.9M10.02%$44.29$3.84-91.3%
10.0%
SPYSPDR S&P 500 ETF TR$426.5M6.44%$400.08$744.78+86.2%
6.4%
ALNYALNYLAM PHARMACEUTICALS INC$285.4M4.31%$169.52$312.78+84.5%
4.3%
DRNADICERNA PHARMACEUTICALS INC$280.7M4.24%β€”β€”
4.2%
VCELVERICEL CORP$237.2M3.58%$52.50$46.98-10.5%
3.6%
MRTXMIRATI THERAPEUTICS INC$235.4M3.55%β€”β€”
3.5%
ILMNILLUMINA INC$228.5M3.45%$460.32$188.68-59.0%
3.5%
PTCTPTC THERAPEUTICS INC$223.8M3.38%$42.27$83.31+97.1%
3.4%
ESTAESTABLISHMENT LABS HLDGS INC$202.6M3.06%$87.34$89.25+2.2%
3.1%
MASIMASIMO CORP$200.3M3.02%$242.45β€”
3.0%
NTRANATERA INC$194.4M2.93%$113.53$279.32+146.0%
2.9%
PTGXPROTAGONIST THERAPEUTICS INC$157.4M2.38%$44.88$131.62+193.3%
2.4%
TXG10X GENOMICS INC$143.8M2.17%$195.82$39.01-80.1%
2.2%
CLDXCELLDEX THERAPEUTICS INC NEW$130.7M1.97%$33.44$38.37+14.7%
2.0%
DMTKQDERMTECH INC$129.6M1.96%β€”β€”
2.0%
GMEDGLOBUS MED INC$129.5M1.95%$77.53$80.12+3.3%
1.9%
AXNXAXONICS INC$123.3M1.86%β€”β€”
1.9%
STOKSTOKE THERAPEUTICS INC$122.7M1.85%$33.66$32.70-2.9%
1.9%
GHGUARDANT HEALTH INC$114.0M1.72%$124.19$167.98+35.3%
1.7%
QDELXXXXQUIDEL CORP$112.6M1.70%β€”β€”
1.7%
TNDMTANDEM DIABETES CARE INC$111.8M1.69%$97.40$15.32-84.3%
1.7%
AXSMAXSOME THERAPEUTICS INC$109.0M1.65%$67.46$244.31+262.2%
1.6%
RNAMAVIDITY BIOSCIENCES INC$98.7M1.49%β€”β€”
1.5%
EPIXESSA PHARMA INC$87.3M1.32%β€”β€”
1.3%
CCCCC4 THERAPEUTICS INC$81.3M1.23%$37.84$4.30-88.6%
1.2%
RXDXPROMETHEUS BIOSCIENCES INC$76.0M1.15%β€”β€”
1.1%
IDYAIDEAYA BIOSCIENCES INC$68.6M1.03%$20.99$37.65+79.4%
1.0%
MGNXMACROGENICS INC$68.4M1.03%$26.86$4.71-82.5%
1.0%
RGNXREGENXBIO INC$68.3M1.03%$38.85$13.28-65.8%
1.0%
AGENAGENUS INC$62.8M0.95%$107.75$3.49-96.8%
0.9%

AttivitΓ  Trimestre su Trimestre

Q2 2021 vs. Q1 2021

Nuove Posizioni (8)

TickerEmittenteNozionale
GHRSGH RESEARCH PLC$42.7M
CUTRQCUTERA INC$35.3M
GLUEMONTE ROSA THERAPEUTICS INC$25.2M
NEONEOGENOMICS INC$13.1M
BMEABIOMEA FUSION INC$12.3M
NAUTNAUTILUS BIOTECHNOLOGY INC$10.4M
SMIHUSUMMIT HEALTHCRE ACQUISTN CO$5.0M
TBIOCODEX DNA INC$4.4M

Posizioni Chiuse (8)

TickerEmittenteNozionale
CERNCerner Corp$127.5M
ARVNArvinas Inc$107.3M
IMVTImmunovant Inc$102.0M
TBIOTranslate Bio Inc$72.3M
CRISCuris Inc$41.0M
KURAKura Oncology Inc$30.6M
ARYAArya Sciences Acquisition Co$6.9M
NUVBNuvation Bio Inc$3.1M

Aumentate (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
EPIXESSA PHARMA INC$79.0M+976.5%
OLKOLINK HLDG AB$36.3M+571.7%
RGNXREGENXBIO INC$54.1M+321.9%-65.8%
GHGUARDANT HEALTH INC$21.0M+50.6%+35.3%
VINCVINCERX PHARMA INC$0.1M+50.0%
LSAQLIFESCI ACQUISITION II CORP$3.2M+50.0%
MASIMASIMO CORP$63.7M+38.9%
IDYAIDEAYA BIOSCIENCES INC$10.6M+32.4%+79.4%

Ridotte (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
XGNEXAGEN INC$-16.1M-49.5%
ITOSITEOS THERAPEUTICS INC$-50.4M-37.9%
ATHAATHIRA PHARMA INC$-29.3M-28.1%
TARSTARSUS PHARMACEUTICALS INC$-20.7M-18.3%
AGENAGENUS INC$25.3M-17.0%-96.8%
BOLTBOLT BIOTHERAPEUTICS INC$-3.0M-15.8%
CTMXCYTOMX THERAPEUTICS INC$-3.0M-8.7%
RCKTROCKET PHARMACEUTICALS INC$-33.4M-4.6%-91.3%
← Torna agli Hedge Fund